News about Market

WHO, WTO and WCO Update Global Customs Codes to Fast-Track Vaccine Shipments by 2028

New customs codes under HS 2028 aim to improve global tracking and faster clearance of vaccines and essential medical supplies during health emergencies.

Market | 04/02/2026 | By News Bureau |  167

SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech

SanegeneBio has licensed one of its RNAi programmes to Genentech in a global collaboration valued at up to USD 1.7 billion, including a USD 200 million upfront payment, milestone-based development and commercialisation payments, and tiered royalties. Genentech will oversee worldwide clinical development and commercialisation.

Market | 03/02/2026 | By News Bureau |  166

Agomab Unveils Plans for Initial Public Offering

Agomab has appointed JP Morgan, Morgan Stanley, Leerink Partners and Van Lanschot Kempen as joint book-running managers for the proposed Initial Public Offering (IPO), marking a key step in its plans to access the public markets.

Market | 03/02/2026 | By News Bureau |  172

Breakthru Medicine Raises USD 60 Million Series A to Advance Cancer Drugs

Founded by biotech veterans Steve Potts, Mark Mulvihill and Brian Barnett, Breakthru Medicine has raised USD 60 million in Series A funding to advance its stealth oncology pipeline, including molecular glues, small molecules and novel ADC payloads.

Market | 02/02/2026 | By News Bureau |  207

AstraZeneca Boosts Weight Management Portfolio via CSPC Collaboration

Under this agreement, Astrazeneca and CSPC Pharmaceuticals will initially progress four programmes, which utilise CSPC's advanced Artificial Intelligence (AI)-driven peptide drug discovery platform and their proprietary LiquidGel once-monthly dosing platform technology.

Market | 31/01/2026 | By News Bureau |  254

Mabtech and Sai Life Sciences Partner to Advance Immunology Research

Under this collaboration, Mabtech and Sai will jointly deliver advanced immunology assay services — including high-sensitivity multiplex cytokine and phenotyping workflows — powered by the EYRA platform installed at Sai’s Boston discovery site.

Market | 31/01/2026 | By News Bureau |  105

Concerto and Sacco System Sign Microbial Discovery Deal

Concerto and Sacco System aim to develop novel ingredients composed of synergistically interacting microbes with desirable functional properties.

Market | 30/01/2026 | By News Bureau |  111

AstraZeneca Commits USD 15 Billion to Expand Manufacturing and R&D in China

UK-based pharmaceutical major AstraZeneca has announced a USD 15 billion investment in China by 2030, marking its largest-ever commitment to the country. The investment is aimed at expanding the company’s research, development and manufacturing capabilities, reinforcing China’s role as a key pillar in AstraZeneca’s global growth strategy.

Market | 30/01/2026 | By Darshana |  125

Evestia Clinical Expands European Footprint with Acquisition of ICRC-Weyer

Evestia Clinical, a global independent specialist contract research organization (CRO), has announced the acquisition of Berlin-based ICRC-Weyer GmbH, a long-established CRO and scientific consultancy with strong expertise in data-driven clinical research.

Market | 29/01/2026 | By Darshana |  119

WuXi Biologics, Sinorda Biomedicine Partner to Advance Bispecific Antibody for Autoimmune Diseases

WuXi Biologics and Sinorda Biomedicine collaborate to accelerate development of SND006, a novel bispecific antibody targeting inflammatory bowel disease and autoimmune disorders.

Market | 29/01/2026 | By News Bureau |  209